🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 67448A106
Business: Obsidian Therapeutics, Inc is a clinical-stage biopharmaceutical company using it proprietary cytoDRiVE® technology to harness novel protein-regulation technology to develop engineered TIL cell therapies for the treatment of patients with solid tumors.
Company Contact
- CEO
- Madan Jagasia
- CFO
- Julie Feder
- Headquarters
- 1030 Massachusetts Avenue, Cambridge, MA 02138
- Phone
- 781-806-6245
- Investor Relations
- info@obsidiantx.com